Terapia adjuvantă cu imunomodulatori în oncologie

In the field of oncology immunotherapy, remarkable discoveries have been made în recent years. The aim of this paper is to cover recent findings în oncology immunotherapy, including the use of inhibitory T cells, modified T cells, anti-cancer vaccines and anti-B and T antibodies. In veterinary oncol...

Full description

Saved in:
Bibliographic Details
Main Authors: Ioana Chiţescu, Diana Mihaela Alexandru, Răzvan Ionuț Dobre, Maria Crivineanu
Format: Article
Language:English
Published: Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar 2023-12-01
Series:Medicamentul Veterinar
Subjects:
Online Access:http://www.veterinarypharmacon.com/docs/2609-2023_VD_17(2)_ART.1.ROM.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the field of oncology immunotherapy, remarkable discoveries have been made în recent years. The aim of this paper is to cover recent findings în oncology immunotherapy, including the use of inhibitory T cells, modified T cells, anti-cancer vaccines and anti-B and T antibodies. In veterinary oncology, immunotherapy is increasingly used due to impressive results. Modified T-cell therapy has demonstrated remarkable tumour control and regression în human subjects, and anticancer vaccines have recently demonstrated long disease-free periods and increased survival time în dogs with lymphoma. Thus, due to the clinical effects obtained, immunomodulators are successfully used în veterinary oncology therapy.
ISSN:1843-9527
2069-2463